India’s COVID-19 caseload climbs to 97.67 lakh; recovery rate at 94.74%, fatalities at 1.45%
Active cases remained below four lakh for the fourth consecutive day. India's COVID-19 tally went past 70 lakh on 11 October, 80 lakh on 29 October and 90 lakh on 20 November
New Delhi: India's COVID-19 caseload climbed to 97,67,371 with 31,521 fresh infections, while the total number of recoveries surged to 92.53 lakh, pushing the national recovery rate to 94.74 percent, according to the Union health ministry data updated on Thursday.
The death toll rose to 1,41,772 with 412 new fatalities, the data updated at 8 am showed. The COVID-19 case fatality rate stands at 1.45 percent.
The number of people who have recuperated from the disease surged to 92,53,306.
The active caseload remained below 4 lakh for the fourth consecutive day. There are 3,72,293 active coronavirus infections in the country which comprise 3.81 percent of the total caseload, the data stated.
India's COVID-19 tally had crossed the 20-lakh mark on 7 August, 30 lakh on 23 August and 40 lakh on 5 September.
It went past 50 lakh on 16 September, 60 lakh on 28 September, 70 lakh on 11 October, 80 lakh on 29 October, and 90 lakh on 20 November.
According to the Indian Council of Medical Research (ICMR), 15,07,59,726 samples had been tested up to 9 December with 9,22,959 samples being tested on Wednesday.
Videos on Chinese social media that said they were filmed at the factory in the central city of Zhengzhou showed thousands of people in masks facing rows of police in white protective suits with plastic riot shields. Postings on social media said they were protesting unspecified contract violations
Case numbers have surged across China, with residents in Beijing worried that a record number of new infections will lead to lockdown measures similar to those seen earlier in the year in Shanghai, which lasted for months
According to the official announcements, local officials are asked to variously remove ‘temporary control orders’ and to redesignate areas as low-risk while also announcing an end to mass PCR testing